Adaptation of the WOMAC for Use in a Patient Preference Study
暂无分享,去创建一个
C. Poulos | C. Mansfield | T. Irony | H. Peay | M. Ho | Xinyi Ng | T. Lee | Sarah Stothers Rosenberg
[1] C. Poulos,et al. MSR17 Logical Soundness in a Discrete Choice Experiment Study of Benefit Risk Preferences , 2022, Value in Health.
[2] A. Bate,et al. Systematic Review of Studies Using Conjoint Analysis Techniques to Investigate Patients’ Preferences Regarding Osteoarthritis Treatment , 2021, Patient preference and adherence.
[3] M. Kloppenburg,et al. Emerging pharmaceutical therapies for osteoarthritis , 2020, Nature Reviews Rheumatology.
[4] C. Cooper,et al. A discrete-choice experiment to assess patients' preferences for osteoarthritis treatment: An ESCEO working group. , 2020, Seminars in arthritis and rheumatism.
[5] S. Grässel,et al. Recent advances in the treatment of osteoarthritis , 2020, F1000Research.
[6] A. Guermazi,et al. Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period , 2020, Annals of the Rheumatic Diseases.
[7] H. Benz,et al. Integrating the Voice of the Patient Into the Medical Device Regulatory Process Using Patient Preference Information. , 2020, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[8] I. Huys,et al. Methods for exploring and eliciting patient preferences in the medical product lifecycle: a literature review. , 2019, Drug discovery today.
[9] A. Holtorf,et al. Patient Preference Studies During Early Drug Development: Aligning Stakeholders to Ensure Development Plans Meet Patient Needs , 2019, Front. Med..
[10] R. Fitzpatrick,et al. Duration of Treatment Effect Should Be Considered in the Design and Interpretation of Clinical Trials: Results of a Discrete Choice Experiment , 2019, Medical decision making : an international journal of the Society for Medical Decision Making.
[11] Alan R. Ellis,et al. Discrete Choice Experiments in Health Economics: Past, Present and Future , 2018, PharmacoEconomics (Auckland).
[12] R. Fitzpatrick,et al. Problems persist in reporting of methods and results for the WOMAC measure in hip and knee osteoarthritis trials , 2018, Quality of Life Research.
[13] D. Felson,et al. Responsiveness of Single versus Composite Measures of Pain in Knee Osteoarthritis , 2018, The Journal of Rheumatology.
[14] D. Gregori,et al. Evaluating therapeutic effect on WOMAC subscales in osteoarthritis RCTs: When model choice matters , 2018, Journal of evaluation in clinical practice.
[15] C. Kwoh,et al. Epidemiology of osteoarthritis: literature update , 2017, Current opinion in rheumatology.
[16] J. Sim,et al. Generating Individual Patient Preferences for the Treatment of Osteoarthritis Using Adaptive Choice-Based Conjoint (ACBC) Analysis , 2017, Rheumatology and Therapy.
[17] Anindita Saha,et al. A Framework for Incorporating Patient Preferences Regarding Benefits and Risks into Regulatory Assessment of Medical Technologies. , 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[18] Elena Losina,et al. Number of Persons With Symptomatic Knee Osteoarthritis in the US: Impact of Race and Ethnicity, Age, Sex, and Obesity , 2016, Arthritis care & research.
[19] P. Smith,et al. Intra-articular Autologous Conditioned Plasma Injections Provide Safe and Efficacious Treatment for Knee Osteoarthritis , 2016 .
[20] A. Carr,et al. Osteoarthritis , 2015, The Lancet.
[21] M. Fransen,et al. Patient preferences for adherence to treatment for osteoarthritis: the MEdication Decisions in Osteoarthritis Study (MEDOS) , 2013, BMC Musculoskeletal Disorders.
[22] S. Sen,et al. A discrete-choice experiment of United Kingdom patients' willingness to risk adverse events for improved function and pain control in osteoarthritis. , 2013, Osteoarthritis and cartilage.
[23] N. Woolacott,et al. The use and reporting of WOMAC in the assessment of the benefit of physical therapies for the pain of osteoarthritis of the knee: findings from a systematic review of clinical trials. , 2012, Rheumatology.
[24] Andrew Lloyd,et al. Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[25] J. Farrar,et al. Outcome measures in placebo-controlled trials of osteoarthritis: responsiveness to treatment effects in the REPORT database. , 2011, Osteoarthritis and cartilage.
[26] A. Leclerc,et al. Impact of osteoarthritis: results of a nationwide survey of 10,000 patients consulting for OA. , 2005, Joint, bone, spine : revue du rhumatisme.
[27] J. Concato,et al. Treatment options in knee osteoarthritis: the patient's perspective. , 2004, Archives of internal medicine.
[28] J. Concato,et al. Informed choice and the widespread use of antiinflammatory drugs. , 2004, Arthritis and rheumatism.
[29] M. Buxton,et al. Patients' preferences for characteristics associated with treatments for osteoarthritis. , 2003, Rheumatology.
[30] A. Davis,et al. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties. , 2001, Arthritis and rheumatism.
[31] C. Goldsmith,et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. , 1988, The Journal of rheumatology.
[32] L. Engebretsen,et al. Clinical Outcomes of Knee Osteoarthritis Treated With an Autologous Protein Solution Injection: A 1-Year Pilot Double-Blinded Randomized Controlled Trial , 2018, American Journal of Sports Medicine.
[33] Telba Irony,et al. Incorporating patient-preference evidence into regulatory decision making , 2014, Surgical Endoscopy.
[34] Deborah Marshall,et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. , 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[35] Mickael Bech,et al. Designing a stated choice experiment: The value of a qualitative process , 2012 .